e-learning resources

Fibrotic CTD and interstitial pneumonia with autoimmune features (IPAF): immunosuppressive or/and anti-fibrotic treatment?

S. Danoff (Baltimore, United States of America)

Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Session: Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
 Session type: Respiratory medicine meets other disciplines
 Number: 4076
Disease area: Interstitial lung diseases
WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Danoff (Baltimore, United States of America). Fibrotic CTD and interstitial pneumonia with autoimmune features (IPAF): immunosuppressive or/and anti-fibrotic treatment?. Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: